BOSTON SCIENTIFIC EXEC SAYS EXPECTS TOP-LINE PRESSURE TO PERSIST INTO 2027, MAKING REVENUE AND EPS GROWTH CHALLENGING EXCLUDING PENUMBRA DEAL

Reuters · 2d ago

Please log in to view news